Last Updated: 18/06/2024

Acquired immunity to malaria: importance of the genetic diversity of Plasmodium falciparum

Objectives

The aim of this project is to further establish how the genetic diversity of P. falciparum infections affects protective immunity to malaria.
The specific objectives of this study are:
1) to investigate polymorphisms in P. falciparum antigen genes, i.e. genes under immune selection, in individuals different levels of exposure and immunity both within and between geographical areas, and identify potential hotspots of transmission 
2) to relate the genetic diversity of P. falciparum infections to the breadth and magnitude of antibody responses directed to a panel of several P. falciparum antigens
3) to study longevity of immune responses (antimalarial antibody and memory B cell responses).

Principal Institution

Karolinska Institute (KI), Sweden

Principal Investigators / Focal Persons

Anna Farnert

Rationale and Abstract

Malaria caused by Plasmodium falciparum is a potentially fatal infection. Understanding how the extensive genetic polymorphism of the parasite affects the acquisition and maintenance of immunity is a prerequisite for the development of efficacious control tools such as vaccines. Previous studies have shown that persistent asymptomatic multiclonal infections predict a reduced risk of disease in high transmission settings. The project includes well defined and closely monitored cohorts living in areas of different transmission in Kenya, Tanzania and Mali, as well as Swedish travellers who experience malaria for the first time. The project will contribute to the understanding of the molecular epidemiology of P. falciparum and the acquisition and maintenance of protective immunity against malaria.

Date

Jan 2013 — Dec 2015

Total Project Funding

$292,606

Funding Details
Swedish Research Council (SRC), Sweden

Grant ID: 2012-03311_VR
SEK 1.91M
Country / Project Site(s)

Kenya
Mali
Sweden
Tanzania

SHARE
SHARE